◼ Archived
Health
How a Promising Pancreatic Cancer Drug Loses Its Punch
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Phase 3 Trial
11 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Vera kidney drug Trutakna shows strong final results in Phase 3 trial
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test
Novartis shares experienced their worst single-day drop in over two decades following the failure of a crucial phase 3 trial for an Avidity buyout drug.
◼ Archived
Business
🔮 fades ✗
Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial
Novo Nordisk's Wegovy shows weight-loss results in young children during trial data releases.
◼ Archived
Business
🔮 fades ✗
Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial
Novartis and Ionis face setbacks as a high-stakes Phase 3 trial for an Lp(a) cardiovascular drug fails to meet its primary goals.
◼ Archived
Business
🔮 fades ✓
Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
GSK advances its mRNA flu vaccine candidate to phase 3 trials following successful mid-stage performance data.
◼ Archived
Health
🔮 fades ✗
Arthritis drug may help regrow up to 80% of hair in alopecia areata
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review
AstraZeneca ends a Phase 3 lung cancer drug trial for volrustomig after a formal review determines success is unlikely.
◼ Archived
Business
🔮 fades ✓
MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial
MoonLake Immunotherapeutics reports that its nanobody drug, sonelokimab, successfully met all clinical endpoints in a Phase 3 trial for psoriatic arthritis.
◼ Archived
Business
🔮 fades
Compass says depression drug has long-lasting benefits
Compass Pathways' psilocybin depression therapy shows six‑month durability, sparking market optimism.